COHEAD Therapeutics
PrivateCompany Overview
COHEAD Therapeutics is a biotechnology company that develops AI-driven covalent inhibitors for targeted cancer therapy.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
drug discoverycovalent inhibitorsAI drug discoverysmall molecule drugsoncology therapeuticscomputational biologyin silico drug designhit-to-leadundruggable targetsmachine learningphysics-based modelingbiotech platformADMET predictionAI-first biotechtechbio
Historical Pricing
Historical view of private secondary pricing and transaction trends.
COHEAD Therapeutics Comparables
Compare COHEAD Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axiom Therapeutics | 88% | |
| Frontier Medicines | 80% | |
| Terray Therapeutics | 77% | |
COHEAD Therapeutics Funding Rounds
Historical fundraising activity
COHEAD Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about COHEAD Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersUnited States
Employee Range1
Year FoundedN/A
Last Funding—
See something wrong or outdated?